Wallstroem; Erik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wallstroem; Erik.The latest application filed is for "therapeutic tyrosine kinase inhibitors for relapsing multiple sclerosis (rms)".

Company Profile

0.2.20

Wallstroem; Erik - Cambridge MA
Wallstroem; Erik - Basel CH
Wallstroem; Erik - Muttenz CH
Wallstroem; Erik - Binningen CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS) App 20210244720 - Cho; Meehyung ; et al.	2021-08-12
Dosage Regimen of Diaryl Sulfide Derivatives App 20180161290 - Gergely; Peter ; et al.	2018-06-14
Amino Alcohol Derivatives For The Treatment Of Demyelinating Peripheral Neuropathies App 20180064660 - LEPPERT; David ; et al.	2018-03-08
Dosage Regimen of Diaryl Sulfide Derivatives App 20170119702 - Gergely; Peter ; et al.	2017-05-04
Amino Alcohol Derivatives For The Treatment Of Demyelinating Peripheral Neuropathies App 20160263060 - LEPPERT; David ; et al.	2016-09-15
Dosage Regimen For An S1p Receptor Modulator Or Agonist App 20150218090 - Wallstroem; Erik	2015-08-06
Dosage Regimen of Diaryl Sulfide Derivatives App 20140336265 - Gergely; Peter ; et al.	2014-11-13
Amino Alcohol Derivatives For The Treatment Of Demyelinating Peripheral Neuropathies App 20140242119 - LEPPERT; David ; et al.	2014-08-28
Use of immunosuppressant compounds in a new indication Grant 8,809,316 - Leppert , et al. August 19, 2	2014-08-19
Use Of Immunosuppressant Compounds In A New Indication App 20140011797 - LEPPERT; David ; et al.	2014-01-09
Dosage Regimen of Diaryl Sulfide Derivatives App 20130210924 - Gergely; Peter ; et al.	2013-08-15
Treatment of Autoimmune Diseases App 20130172297 - Gergely; Peter ; et al.	2013-07-04
Use Of Immunosuppressant Compounds In A New Indication App 20110190398 - Leppert; David ; et al.	2011-08-04
Compounds For The Treatment Of Peripheral Neuropathies App 20110144082 - Leppert; David ; et al.	2011-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.